<VariationArchive VariationID="11052" VariationName="NC_000023.11:g.5250357_6007153del" VariationType="Deletion" Accession="VCV000011052" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2016-09-25" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26091" VariationID="11052">
      <GeneList>
        <Gene Symbol="NLGN4X" FullName="neuroligin 4 X-linked" GeneID="57502" HGNC_ID="HGNC:14287" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xp22.32-22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="5890042" stop="6228867" display_start="5890042" display_stop="6228867" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="5808082" stop="6146705" display_start="5808082" display_stop="6146705" Strand="-" />
          </Location>
          <OMIM>300427</OMIM>
          <Haploinsufficiency last_evaluated="2012-03-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NLGN4X">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-03-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NLGN4X">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.5250357_6007153del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.33</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>757-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="NCBI36" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.9" sequenceAccession="NC_000023" sequenceVersion="9" change="g.5178398_5935194del" Assembly="NCBI36">
            <Expression>NC_000023.9:g.5178398_5935194del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.5250357_6007153del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.5250357_6007153del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv1415011" DB="dbVar" />
        <XRef ID="nsv513783" DB="dbVar" />
        <XRef Type="Allelic variant" ID="300427.0003" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 300427.0003 from the location reported in the legend of Figure 3 of the paper by Lawson-Yuen et al., 2008 (PubMed 18231125).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.5250357_6007153del AND Autism, susceptibility to, X-linked 2" Accession="RCV000032597" Version="11">
        <ClassifiedConditionList TraitSetID="3061">
          <ClassifiedCondition DB="MedGen" ID="C1845539">Autism, susceptibility to, X-linked 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-05-01" SubmissionCount="1">risk factor</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.11:g.5250357_6007153del AND X-linked intellectual disability" Accession="RCV004558245" Version="1">
        <ClassifiedConditionList TraitSetID="48262">
          <ClassifiedCondition DB="MedGen" ID="C1136249">X-linked intellectual disability</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-05-01" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2016-09-25" MostRecentSubmission="2024-06-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic; risk factor</Description>
        <Citation Type="general">
          <ID Source="PubMed">18231125</ID>
        </Citation>
        <DescriptionHistory Dated="2024-06-06">
          <Description>risk factor</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-03-17">
          <Description>Pathogenic; risk factor</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-03-18">
          <Description>Pathogenic, risk factor</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3061" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="366" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autism, susceptibility to, X-linked 2</ElementValue>
                <XRef ID="MONDO:0010341" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AUTSX2</ElementValue>
                <XRef Type="MIM" ID="300495" DB="OMIM" />
              </Symbol>
              <XRef ID="C1845539" DB="MedGen" />
              <XRef ID="MONDO:0010341" DB="MONDO" />
              <XRef Type="MIM" ID="300495" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="48262" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41958" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED</ElementValue>
                <XRef Type="Allelic variant" ID="300427.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300427.0003" DB="OMIM" />
                <XRef ID="300495" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked intellectual disability</ElementValue>
                <XRef ID="MONDO:0100284" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XLMR</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XLID</ElementValue>
              </Symbol>
              <XRef ID="C1136249" DB="MedGen" />
              <XRef ID="MONDO:0100284" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9796655" SubmissionDate="2023-03-03" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="300427.0003_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED" title="NLGN4X, 757-KB DEL_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED" />
        <ClinVarAccession Accession="SCV005046841" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a boy with autism and intellectual developmental disorder (300495) as well as a motor tic, Lawson-Yuen et al. (2008) identified a hemizygous deletion in the NLGN4 gene encompassing exons 4, 5, and 6. The 757-kb deletion was predicted to result in a significantly truncated protein. The patient's 9-year-old brother, who carried diagnoses of Tourette syndrome (see 309840) and attention deficit-hyperactivity disorder with mild cognitive deficits, also carried the deletion. The mother, who was a carrier, had a learning disability, depression, and anxiety. Lawson-Yuen et al. (2008) concluded that NLGN4 mutations can be associated with a wide spectrum of neuropsychiatric disorders.</Attribute>
              <Citation>
                <ID Source="PubMed">18231125</ID>
              </Citation>
              <XRef DB="OMIM" ID="300495" Type="MIM" />
              <XRef DB="OMIM" ID="309840" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NLGN4X" />
          </GeneList>
          <Name>NLGN4X, 757-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">757-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300427.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="93541" SubmissionDate="2016-09-22" DateLastUpdated="2024-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300427.0003_AUTISM, SUSCEPTIBILITY TO, X-LINKED 2" title="NLGN4X, 757-KB DEL_AUTISM, SUSCEPTIBILITY TO, X-LINKED 2" />
        <ClinVarAccession Accession="SCV000056348" DateUpdated="2024-06-09" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>risk factor</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a boy with autism and intellectual developmental disorder (300495) as well as a motor tic, Lawson-Yuen et al. (2008) identified a hemizygous deletion in the NLGN4 gene encompassing exons 4, 5, and 6. The 757-kb deletion was predicted to result in a significantly truncated protein. The patient's 9-year-old brother, who carried diagnoses of Tourette syndrome (see 309840) and attention deficit-hyperactivity disorder with mild cognitive deficits, also carried the deletion. The mother, who was a carrier, had a learning disability, depression, and anxiety. Lawson-Yuen et al. (2008) concluded that NLGN4 mutations can be associated with a wide spectrum of neuropsychiatric disorders.</Attribute>
              <Citation>
                <ID Source="PubMed">18231125</ID>
              </Citation>
              <XRef DB="OMIM" ID="300495" Type="MIM" />
              <XRef DB="OMIM" ID="309840" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NLGN4X" />
          </GeneList>
          <Name>NLGN4X, 757-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">757-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300427.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AUTISM, SUSCEPTIBILITY TO, X-LINKED 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="93541" TraitType="Disease" MappingType="Name" MappingValue="AUTISM, SUSCEPTIBILITY TO, X-LINKED 2" MappingRef="Preferred">
        <MedGen CUI="C1845539" Name="Autism, susceptibility to, X-linked 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9796655" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED" MappingRef="Alternate">
        <MedGen CUI="C1136249" Name="X-linked intellectual disability" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2023-03-15">SCV000032034</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

